Search Results 1281-1290 of 18040 for multiple%20sclerosis
Multiple sclerosis or; Optic neuritis (eye problem) ... Weighing 15 kg to less than 30 kg—20 mg injected under the skin every other week. ... Weighing 15 kg to less ...
About this study. The purpose of this study is to establish the Recommended Phase 2 Dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), ...
... multiple myeloma. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs ...
Dennis Douda. July 20, 2016. Wellness Coaching Can Produce Significant and Long-term Improvements in Health Behaviors featured image. Featured News. Wellness ...
Graves' disease is an autoimmune disorder that triggers the thyroid gland to produce more thyroid hormones than the body needs. It's the most common cause[...] ...
About this study. Primary Objective: - Part A: To evaluate the safety of SAR650984 (isatuximab) in patients with relapsed/refractory multiple myeloma (RRMM) ...
October 20, 2020. Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ vaccine featured image. Cancer. Mayo Clinic Q&A podcast: Clinical trial ...
This causes symptoms such as blurred central vision or a blind spot in the center of the visual field. There are two types — wet macular degeneration and dry ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18 ... August 20, 2013. Minnesota. Four Projects Awarded Discovery Transformation ...
Mayo Clinic researchers study new class of drugs to treat multiple myeloma. Joe Dangor. June 14, 2021. Cancer. Model Clarifies Immunotherapy for Multiple ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.